Alfred Caronia Orphan Medical

At Manningham Medical Centre, you can find all the data about Alfred Caronia Orphan Medical. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.

United States v. Caronia, 703 F.3d 149 (2012): Case Brief …

https://www.quimbee.com/cases/united-states-v-caronia

Alfred Caronia (defendant) was a pharmaceutical sales representative for Orphan Medical, Inc. (Orphan). Orphan produced the drug Xyrem, a central nervous system depressant whose active ingredient was gamma-hydroxybutyrate. Gamma-hydroxybutyrate—also known as GHB—could cause serious side effects and medical problems and was also classified as a drug used by perpetrators of date rapes.

Caronia v. Orphan Med., Inc., 643 F. App'x 61 | Casetext …

https://casetext.com/case/caronia-v-orphan-med-inc

Alfred Caronia and Dorothy Sciallo appeal from the August 13, 2015 memorandum and order and judgment of the United States District Court for the Eastern District of New York …

U.S. v. Caronia: what are the implications? - Lexology

https://www.lexology.com/library/detail.aspx?g=1992ca29-7737-4332-b506-bb292d3b2491

Alfred Caronia was a pharmaceuticals sales representative for Orphan Medical who, together witha physician in Orphan's speaker program, promoted the…

UNITED STATES v. CARONIA (2012) | FindLaw

https://caselaw.findlaw.com/us-2nd-circuit/1617010.html

Under Orphan's procedures, if Caronia, as a sales consultant for Xyrem, was asked about the off-label use of Xyrem, he was not permitted to answer; instead, when …

United States v. Alfred Caronia, 06-CR-229 - New York …

https://www.law.com/newyorklawjournal/nycid/103794/

Orphan manufactured the drug Xyrem, a powerful sleep-inducing depressant whose active ingredient was gamma-hydroxybutryate (“GHB”). 1 In July 2002, …

First Amendment & Pharma: Taking Freedom of Information …

https://blog.petrieflom.law.harvard.edu/2012/12/04/first-amendment-pharma-taking-freedom-of-information-seriously/

Caronia, involved the conviction of Alfred Caronia, a former sales representative for Orphan Medical, which was later acquired by Jazz Pharmaceutical. …

Off-Label Drug Marketing Is 'Free Speech,' Court Rules

https://abcnews.go.com/Health/Drugs/off-label-drug-marketing-free-speech-court-rules/story?id=17883930

The case involves Alfred Caronia, a sales representative with Orphan Medical who was criminally prosecuted for making off-label promotional statements …

Off-Label Promotion Is Free Speech - U.S. Pharmacist

https://www.uspharmacist.com/article/off-label-promotion-is-free-speech

Alfred Caronia was a sales representative for Orphan Medical (acquired by Jazz Pharmaceutical in 2005), the manufacturer of Xyrem (sodium oxybate). 1 The drug …

United States v. Caronia: A Victory for Free Speech vs.

https://www.policymed.com/2012/12/united-states-v-caronia-a-victory-for-free-speech-vs-off-label-promotion.html

On appeal, Caronia principally argued that the misbranding provisions of the FDCA prohibit off-label promotion, and therefore, unconstitutionally restrict speech.8 …

The US Caronia case: truthful off-label communications by ...

https://content.next.westlaw.com/practical-law/document/I8417d75e1cb111e38578f7ccc38dcbee/The-US-Caronia-case-truthful-off-label-communications-by-pharmaceutical-companies?viewType=FullText&contextData=(sc.Default)

The Caronia case began in 2005, when the US government launched an investigation into Orphan Medical, Inc. (Orphan), a wholly-owned subsidiary of Jazz …

Need more information about Alfred Caronia Orphan Medical?

At Manningham Medical Centre, we collected data on more than just Alfred Caronia Orphan Medical. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.